Show Notes
Summary
This episode of the Irish Hematology Oncology podcast explores the importance of ancillary medications in chemotherapy regimens. The host discusses specific medications used to address the side effects and risks of chemotherapy drugs, including Pemetrexed with vitamin B12 and folic acid, Docetaxel with corticosteroids, Irinotecan with atropine, and 5-FU with leucovorin. Each medication is explained in detail, highlighting its role in managing side effects and enhancing the effectiveness of chemotherapy.
Takeaways
Ancillary medications play a crucial role in managing side effects and enhancing the effectiveness of chemotherapy drugs.
Pemetrexed can deplete the body's stores of vitamin B12 and folic acid, so supplementation is necessary to prevent deficiencies and reduce the risk of severe side effects.
Corticosteroids like dexamethasone are prescribed alongside Docetaxel to manage fluid retention.
Atropine is used as an antidote to counteract the cholinergic reaction caused by Irinotecan.
Leucovorin is used to protect healthy cells and enhance the action of 5-FU in chemotherapy.
Consult with healthcare professionals for personalized guidance and stay updated on the latest recommendations in cancer care.
IIOP CPD Example: https://docs.google.com/document/d/1d1KEtJ6yrZ_fMGMLgTFgQ762rX0-y5vbb4ikDsr_U6s/edit?usp=sharing
Feedback Form: https://forms.gle/ortbvq6Ld19zSCDG7
More from Irish Haematology Oncology Podcast
Eoin Tabb reports from Day 3 of the ISOPP CAPhO 2025 Symposium in Victoria, Canada. This episode delves into crucial discussions on Equity, Diversity, and Inclusion (EDI) in pharmacy practice, the benefits and risks of Artificial Intelligence (AI) in oncology, updates on preventing Cancer-Associated Thrombosis (CAT), and the implementation of pre-therapeutic Pharmacogenomics (PGx), including combining DPYD testing with Therapeutic Drug Monitoring (TDM) for 5-FU. Plus, hear exciting news from the ISOPP AGM about next year's unique 24-hour virtual conference format and a special collaboration with the Irish Pharmacy Haematology Oncology Society (IPHOS)! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy #EDI #AI #PGx #TDM #CAT CAT Survey: https://redcap.alfredhealth.org.au/redcap/surveys/index.php?s=dFo7DpNgVBauTYeW&__startover=1
Join Eoin Tabb for the second daily dispatch from the ISOPP CAPhO 2025 Symposium in Victoria, Canada. Day 2 covered a wide spectrum of crucial topics for haematology/oncology pharmacy practice. Highlights include practical management strategies for PARP inhibitors, the importance of cultural humility and discussing traditional medicines, ISOPP's new global service level framework, pharmacy's role in disaster preparedness and environmental sustainability, efficiencies in myeloma treatment administration (pre-meds, infusion times, schedules), managing CMV infections, considerations for treating older/unfit patients using geriatric assessment, and critical updates on hazardous drug lists and safety. Tune in for key insights and takeaways relevant to Irish practice! #ISOPPCAPhO2025 #OncologyPharmacy #Haematology #ClinicalPharmacy PARPi Clinical Resource: https://cdn.ymaws.com/www.cano-acio.ca/resource/resmgr/endorsements/en_parp_inhibitor_clinical_r.pdf
Join host Eoin Tabb for a special dispatch episode recorded live from the ISOPP 2025 Symposium in Victoria, BC. Get your 'audio delegate bag' with key insights from Day 1, covering: